Will the FDA approve at least 50 new drugs in 2026?
Current probability of “Yes”: 50%
- Status
- Open
- Category
- Science
- Closing date
- 20 January 2027
- Participants
- 0
VangAI analysis
VangAI estimate: +5% for “Yes”, confidence 70%
- Historical data shows that the FDA approves an average of 47 new drugs per year over the past decade.
- In 2024, 50 new drugs were approved, matching the threshold value.
- In 2025, the number of approvals decreased to 46, below the threshold value.
- Recent FDA initiatives to expedite the approval process may lead to an increase in approvals in 2026.
Like weather that is usually warm but occasionally turns cold.
Market rules
"Yes" if, on the official FDA page "Novel Drug Approvals for 2026" (https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026) as of January 20, 2027, 12:00 UTC, there are 50 or more approvals listed for the 2026 calendar year. Numeric threshold: >= 50 entries (field "Showing 1 to N of N entries" / maximum number in column No.). Reference as of 08.03.2026: 29 drugs are listed, latest approvals from 07.24.2026, page updated 07.29.2026. Otherwise, "No". Edge cases: only drugs included by the FDA in this list (novel drugs CDER) are counted; approvals added to the page after January 20, 2027, are not counted, even if the approval date relates to 2026; exactly 50 — "Yes"; subsequent removal of an entry from the list does not change the outcome. If the page is temporarily unavailable or updated with delay, the result is fixed based on the same page within 72 hours after the resolution date.